Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2013 2
2015 3
2018 1
2019 3
2020 3
2021 4
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean kamble s[au] (265 results)?
Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells.
Zhou L, Huntington K, Zhang S, Carlsen L, So EY, Parker C, Sahin I, Safran H, Kamle S, Lee CM, Lee CG, Elias JA, Campbell KS, Naik MT, Atwood WJ, Youssef E, Pachter JA, Navaraj A, Seyhan AA, Liang O, El-Deiry WS. Zhou L, et al. Among authors: kamle s. bioRxiv. 2020 Sep 2:2020.08.02.230839. doi: 10.1101/2020.08.02.230839. Preprint. bioRxiv. 2020. PMID: 32793908 Free PMC article.
A human leucyl-tRNA synthetase as an anticancer target.
Gao G, Yao Y, Li K, Mashausi DS, Li D, Negi H, Kamle S, Chen H, Wu Z, Zhou H, Li D. Gao G, et al. Among authors: kamle s. Onco Targets Ther. 2015 Oct 15;8:2933-42. doi: 10.2147/OTT.S88873. eCollection 2015. Onco Targets Ther. 2015. PMID: 26508878 Free PMC article.
22 results